WEBSITE BSE:521167 NSE: MAXGROW Inc. Year: 1994 Industry: Trading My Bucket: Add Stock
Last updated: 00:00
No Notes Added Yet
Maxgrow India Limited is an agri-inputs and biotechnology-based company engaged primarily in the business of manufacturing, marketing, and trading of agricultural products such as fertilizers, micronutrients, soil conditioners, bio-stimulants, and other crop nutrition solutions. The company focuses on improving soil health and crop productivity through sustainable and technology-driven farming inputs, catering mainly to the Indian agricultural market through a growing distributor and dealer network. Over the years, Maxgrow has positioned itself...Read More
Maxgrow India Limited is an agri-inputs and biotechnology-based company engaged primarily in the business of manufacturing, marketing, and trading of agricultural products such as fertilizers, micronutrients, soil conditioners, bio-stimulants, and other crop nutrition solutions. The company focuses on improving soil health and crop productivity through sustainable and technology-driven farming inputs, catering mainly to the Indian agricultural market through a growing distributor and dealer network. Over the years, Maxgrow has positioned itself in the fast-growing specialty fertilizers and organic farming segment, which benefits from rising demand for sustainable agriculture and higher farm yields. The company operates as a small but expanding player in the agri-inputs space, with its performance closely linked to monsoon conditions, government agricultural policies, and rural demand trends. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹234 Cr.
Stock P/E 7.9
P/B -
Current Price ₹58.5
Book Value ₹ 0
Face Value 5
52W High ₹73.4
Dividend Yield 0%
52W Low ₹ 7.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2011 | Jun 2012 | Sep 2013 | Dec 2013 | Jun 2014 | Sep 2014 | Dec 2014 | Jun 2015 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2 | 4 | 4 | 4 | 4 | 5 | 1 | 3 | 3550 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 2 | 4 | 4 | 4 | 4 | 5 | 1 | 3 | 3550 |
| Total Expenditure | 2 | 4 | 4 | 5 | 4 | 5 | 1 | 3 | 3481 |
| Operating Profit | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 69 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | -1 | -0 | 0 | 0 | 0 | 69 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 0 | -1 | -0 | 0 | 0 | 0 | 69 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Profit After Adjustments | 0 | 0 | 0 | -1 | -0 | 0 | 0 | 0 | 69 |
| Adjusted Earnings Per Share | 0 | 0.2 | 0 | -0.2 | -0 | 0 | 0 | 0 | 17.2 |
| #(Fig in Cr.) | Mar 2025 | TTM |
|---|---|---|
| Net Sales | 2758 | 3559 |
| Other Income | 0 | 0 |
| Total Income | 2758 | 3559 |
| Total Expenditure | 2707 | 3490 |
| Operating Profit | 50 | 69 |
| Interest | 0 | 0 |
| Depreciation | 0 | 0 |
| Exceptional Income / Expenses | -21 | 0 |
| Profit Before Tax | 30 | 69 |
| Provision for Tax | 0 | 0 |
| Profit After Tax | 30 | 69 |
| Adjustments | 0 | 0 |
| Profit After Adjustments | 30 | 69 |
| Adjusted Earnings Per Share | 7.4 | 17.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | 245% | 111% | 29% |
| ROE Average | 2% | 2% | 2% | 2% |
| ROCE Average | 2% | 2% | 2% | 2% |
| #(Fig in Cr.) | Mar 2025 |
|---|---|
| Shareholder's Funds | 1464 |
| Minority's Interest | 0 |
| Borrowings | 165 |
| Other Non-Current Liabilities | 4 |
| Total Current Liabilities | 524 |
| Total Liabilities | 2158 |
| Fixed Assets | 5 |
| Other Non-Current Assets | 48 |
| Total Current Assets | 2105 |
| Total Assets | 2158 |
| #(Fig in Cr.) | Mar 2025 |
|---|---|
| Opening Cash & Cash Equivalents | 9 |
| Cash Flow from Operating Activities | 41 |
| Cash Flow from Investing Activities | 0 |
| Cash Flow from Financing Activities | -43 |
| Net Cash Inflow / Outflow | -1 |
| Closing Cash & Cash Equivalent | 8 |
| # | Mar 2025 |
|---|---|
| Earnings Per Share (Rs) | 7.43 |
| CEPS(Rs) | 7.47 |
| DPS(Rs) | 0 |
| Book NAV/Share(Rs) | 366.49 |
| Core EBITDA Margin(%) | 1.83 |
| EBIT Margin(%) | 1.08 |
| Pre Tax Margin(%) | 1.08 |
| PAT Margin (%) | 1.08 |
| Cash Profit Margin (%) | 1.08 |
| ROA(%) | 1.38 |
| ROE(%) | 2.03 |
| ROCE(%) | 1.69 |
| Receivable days | 277.59 |
| Inventory Days | 0 |
| Payable days | 50.68 |
| PER(x) | 0 |
| Price/Book(x) | 0 |
| Dividend Yield(%) | 0 |
| EV/Net Sales(x) | 0.11 |
| EV/Core EBITDA(x) | 6.14 |
| Net Sales Growth(%) | 0 |
| EBIT Growth(%) | 0 |
| PAT Growth(%) | 0 |
| EPS Growth(%) | 0 |
| Debt/Equity(x) | 0.2 |
| Current Ratio(x) | 4.01 |
| Quick Ratio(x) | 4.01 |
| Interest Cover(x) | 1286.33 |
| Total Debt/Mcap(x) | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 16.22 | 16.22 | 16.22 | 16.22 | 92.82 | 92.82 | 92.82 | 92.82 | 92.82 | 92.82 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 83.77 | 83.77 | 83.77 | 83.77 | 7.18 | 7.18 | 7.18 | 7.18 | 7.18 | 7.18 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.35 | 0.35 | 0.35 | 0.35 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 1.79 | 1.79 | 1.79 | 1.79 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.13 | 2.13 | 2.13 | 2.13 | 3.99 | 3.99 | 3.99 | 3.99 | 3.99 | 3.99 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
